namisouthbay.com
New Drug “ITI-007” Shows Promise for Schizophrenia
A new medication, now in phase 3 clinical development for the treatment of schizophrenia, is showing great promise, according to its manufacturer and developer, Intra-Cellular Therapies Inc., as pr…